Thalamic cholinergic innervation is spared in Alzheimer disease compared to parkinsonian disorders

Neuroscience Letters

Volumn 514, Issue 2, 2012, Pages 169-172

  Kotagal, Vikas ^a   Müller, Martijn L T M ^a,e   Kaufer, Daniel I ^b,f   Koeppe, Robert A ^a   Bohnen, Nicolaas I ^a,c,d  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c VAAAHS   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e Lobby B 1000   (United States)

^f SPC 5610 ^*  (United States)

Author keywords

Acetylcholine; Alzheimer disease; Parkinson disease; Parkinson disease with dementia; Pedunculopontine nucleus (PPN)

Indexed keywords

ACETYLCHOLINESTERASE; ACETYLCHOLINESTERASE METHYL 4 PIPERIDINYL PROPIONATE C 11; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DEMENTIA; DIFFUSE LEWY BODY DISEASE; ENZYME ACTIVITY; FEMALE; HUMAN; HYDROLYSIS; KRUSKAL WALLIS TEST; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARASYMPATHETIC INNERVATION; PARKINSON DISEASE; PARKINSON DISEASE WITH DEMENTIA; PARKINSON DISEASE WITHOUT DEMENTIA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; THALAMUS;

EID: 84863398698     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2012.02.083     Document Type: Article

References (27)

1. Aarsland D., Bronnick K., Williams-Gray C., Weintraub D., Marder K., Kulisevsky J., Burn D., Barone P., Pagonabarraga J., Allcock L., Santangelo G., Foltynie T., Janvin C., Larsen J.P., Barker R.A., Emre M. Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis. Neurology 2010, 75:1062-1069.
2. A.P. Association, Diagnostic and Statistical Manual of Mental Disorders, fourth ed., Washington, DC, 1994.
3. Baba Y., Putzke J.D., Whaley N.R., Wszolek Z.K., Uitti R.J. Gender and the Parkinson's disease phenotype. J. Neurol. 2005, 252:1201-1205.
4. Bohnen N.I., Kaufer D.I., Ivanco L.S., Lopresti B., Koeppe R.A., Davis J.G., Mathis C.A., Moore R.Y., DeKosky S.T. Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study. Arch. Neurol. 2003, 60:1745-1748.
5. Bohnen N.I., Muller M.L., Koeppe R.A., Studenski S.A., Kilbourn M.A., Frey K.A., Albin R.L. History of falls in Parkinson disease is associated with reduced cholinergic activity. Neurology 2009, 73:1670-1676.
6. Brandel J.P., Hirsch E.C., Malessa S., Duyckaerts C., Cervera P., Agid Y. Differential vulnerability of cholinergic projections to the mediodorsal nucleus of the thalamus in senile dementia of Alzheimer type and progressive supranuclear palsy. Neuroscience 1991, 41:25-31.
7. Davies P., Maloney A.J. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet 1976, 2:1403.
8. Dugger B.N., Murray M.E., Boeve B.F., Parisi J.E., Benarroch E.E., Ferman T.J., Dickson D.W. Neuropathological analysis of brainstem cholinergic and catecholaminergic nuclei in relation to REM sleep behaviour disorder. Neuropathol. Appl. Neurobiol. 2012, 38:142-152.
9. Geula C., Mesulam M.M. Systematic regional variations in the loss of cortical cholinergic fibers in Alzheimer's disease. Cereb. Cortex 1996, 6:165-177.
10. Heckers S., Geula C., Mesulam M.M. Cholinergic innervation of the human thalamus: dual origin and differential nuclear distribution. J. Comp. Neurol. 1992, 325:68-82.
11. Irie T., Fukushi K., Akimoto Y., Tamagami H., Nozaki T. Design and evaluation of radioactive acetylcholine analogs for mapping brain acetylcholinesterase (AchE) in vivo. Nucl. Med. Biol. 1994, 21:801-808.
12. Janvin C.C., Larsen J.P., Aarsland D., Hugdahl K. Subtypes of mild cognitive impairment in Parkinson's disease: progression to dementia. Mov. Disord. 2006, 21:1343-1349.
13. Janzen J., van't Ent D., Lemstra A.W., Berendse H.W., Barkhof F., Foncke E.M. The pedunculopontine nucleus is related to visual hallucinations in Parkinson's disease: preliminary results of a voxel-based morphometry study. J. Neurol. 2012, 259:147-154.
14. Kehagia A.A., Barker R.A., Robbins T.W. Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease. Lancet Neurol. 2010, 9:1200-1213.
15. V. Kotagal, R.L. Albin, M.L. Muller, R.A. Koeppe, R.D. Chervin, K.A. Frey, N.I. Bohnen, Symptoms of rapid eye movement sleep behavior disorder are associated with cholinergic denervation in Parkinson disease, Ann. Neurol., in press. doi:10.1002/ana.22691.
16. Kuhl D.E., Koeppe R.A., Minoshima S., Snyder S.E., Ficaro E.P., Foster N.L., Frey K.A., Kilbourn M.R. In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer's disease. Neurology 1999, 52:691-699.
17. McKeith I.G., Perry E.K., Perry R.H. Report of the second dementia with Lewy body international workshop: diagnosis and treatment. Consortium on dementia with Lewy bodies. Neurology 1999, 53:902-905.
18. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984, 34:939-944.
19. Mesulam M. The cholinergic lesion of Alzheimer's disease: pivotal factor or side show?. Learn. Mem. 2004, 11:43-49.
20. Mesulam M.M., Geula C., Bothwell M.A., Hersh L.B. Human reticular formation: cholinergic neurons of the pedunculopontine and laterodorsal tegmental nuclei and some cytochemical comparisons to forebrain cholinergic neurons. J. Comp. Neurol. 1989, 283:611-633.
21. Minoshima S., Koeppe R.A., Frey K.A., Kuhl D.E. Anatomic standardization: linear scaling and nonlinear warping of functional brain images. J. Nucl. Med. 1994, 35:1528-1537.
22. Minoshima S., Koeppe R.A., Mintun M.A., Berger K.L., Taylor S.F., Frey K.A., Kuhl D.E. Automated detection of the intercommissural line for stereotactic localization of functional brain images. J. Nucl. Med. 1993, 34:322-329.
23. Nagatsuka Si S., Fukushi K., Shinotoh H., Namba H., Iyo M., Tanaka N., Aotsuka A., Ota T., Tanada S., Irie T. Kinetic analysis of [(11)C]MP4A using a high-radioactivity brain region that represents an integrated input function for measurement of cerebral acetylcholinesterase activity without arterial blood sampling. J. Cereb. Blood Flow Metab. 2001, 21:1354-1366.
24. Shute C.C., Lewis P.R. Electron microscopy of cholinergic terminals and acetylcholinesterase-containing neurones in the hippocampal formation of the rat. Z. Zellforsch. Mikrosk. Anat. 1966, 69:334-343.
25. 11C]PMP) for in vivo measurements of acetylcholinesterase activity. Nucl. Med. Biol. 1998, 25:751-754.
26. Whitehouse P.J., Price D.L., Struble R.G., Clark A.W., Coyle J.T., Delon M.R. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science 1982, 215:1237-1239.
27. Woolf N.J., Jacobs R.W., Butcher L.L. The pontomesencephalotegmental cholinergic system does not degenerate in Alzheimer's disease. Neurosci. Lett. 1989, 96:277-282.